Connect Biopharma Holdings LTD 8-K Filing
Ticker: CNTB · Form: 8-K · Filed: Dec 23, 2025 · CIK: 1835268
Sentiment: neutral
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 11.7 · Accepted 2025-12-23 16:32:02
Key Financial Figures
- $0.000174 — registered Ordinary Shares, par value $0.000174 per Share CNTB The Nasdaq Global Market
Filing Documents
- cntb-20251217.htm (8-K) — 25KB
- 0001835268-25-000061.txt ( ) — 140KB
- cntb-20251217.xsd (EX-101.SCH) — 2KB
- cntb-20251217_lab.xml (EX-101.LAB) — 22KB
- cntb-20251217_pre.xml (EX-101.PRE) — 13KB
- cntb-20251217_htm.xml (XML) — 3KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CONNECT BIOPHARMA HOLDINGS LIMITED Date: December 23, 2025 By: /s/ David Szekeres Name: David Szekeres Title: President